Schedule 13G ownership disclosure

Odonate Therapeutics, Inc.

Security class unavailable · CUSIP: 676079106

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,771,744
Percent of class
9.7900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-21-000287
Form type
SC 13G/A
Filer
Odonate Therapeutics, Inc.
CIK
CIK 1717452
Filed
Feb 04, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SC 13G/A | SEC Filings Hub